In response to the unremitting rise of childhood obesity in the United States,1,2 a growing body of literature supports the utilization of metabolic and bariatric surgery (MBS) for the treatment of severe obesity (body mass index [BMI] ≥120% of the 95th percentile or BMI ≥35 kg/m2) in the pediatric population.3–5 In addition to offering important insight regarding the physiologic and psychosocial phenotypes observed among individuals presenting for MBS, numerous studies to date have shown improvement and/or complete resolution of most comorbid conditions with significant improvements in quality of life. Despite favorable results and a recent rise in procedural prevalence, ongoing controversy, including professional bias related to the treatment of childhood obesity and misinformation among the general public, access to care remains limited compared with the corresponding adult population.6–10 In a series of recently published policy statements and clinical practice guidelines, the American Academy of Pediatrics (AAP) and the American Society of Metabolic and Bariatric Surgery have recommended approaches to address disparities in the use of MBS in the pediatric population and have unambiguously stated that pediatric health care providers should refer eligible patients to comprehensive multidisciplinary pediatric MBS centers.2–4